| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | Director | Ordinary Shares | 6.93K | $771K | $111.25 | Aug 8, 2025 | Direct |
| ANAPTYSBIO, INC | Director | Restricted Stock Unit | 3.9K | $85.1K | $21.81 | Jan 6, 2023 | Direct |
| Y-mAbs Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $8.52 | Sep 16, 2025 | Direct |
| Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 250K | Jan 17, 2023 | Direct | ||
| ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 10.6K | Jan 6, 2023 | Direct | ||
| ACCELERON PHARMA INC | Director | Common Stock | 0 | $175.00 | Nov 19, 2021 | Direct | |
| ACCELERON PHARMA INC | Director | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
| PARDES BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 0 | Aug 31, 2023 | Direct | ||
| Y-mAbs Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 0 | Sep 16, 2025 | Direct |